Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
4.760
-0.010 (-0.21%)
At close: Jul 19, 2024, 4:00 PM
4.520
-0.240 (-5.04%)
Pre-market: Jul 22, 2024, 7:44 AM EDT
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $178.33 million as of July 22, 2024.
Market Cap
178.33M
Enterprise Value
-106.26M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.76
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $178.33M, a decrease of -68.32%. That is a compound annual growth rate of -92.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 178.30M | -68.33% |
| Feb 9, 2024 | 562.92M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adverum Biotechnologies | 178.42M |
| Innate Pharma | 177.60M |
| Fennec Pharmaceuticals | 176.50M |
| Coherus BioSciences | 176.10M |
| MediWound | 176.02M |
| FibroBiologics | 173.59M |
| Puma Biotechnology | 172.21M |
| Acumen Pharmaceuticals | 172.13M |